, Eric M. Wallen1 and Matthew E. Nielsen1
(1)
Department of Urology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Abstract
Clinical care pathways have been shown to enhance patient care. This chapter focuses on the clinical care pathway for patients undergoing a radical cystectomy, either by an open or by a robot-assisted laparoscopic approach. Highlights of the pathway include preoperative preparation, perioperative antibiotics, analgesia usage, advancement of diet, early ambulation, DVT prophylaxis, and general postoperative care. Streamlining such clinical care pathways enhance our commitment to providing high quality care to all of our patients.
Introduction
Bladder cancer has a significant burden of disease in the USA. As the fourth most common malignancy, there are over 70,000 new diagnoses of bladder cancer each year [1]. The incidence has risen by 40 % since 1975 and a significant proportion, approximately one in four new cases, present at an advanced stage, for which radical cystectomy is the reference standard treatment. Bladder cancer continues to confer significant disease-specific mortality to patients inflicted with the illness [1]. Furthermore, while 75 % of newly diagnosed bladder cancers are non-muscle invasive at the time of presentation, 50–75 % of these patients have recurrent disease and 15–30 % progress to muscle-invasive disease [2].
The treatment of bladder cancer encompasses many modalities including endoscopic resection, intravesical therapies, chemotherapy, radiation therapy, and surgery [2–4, 27]. In many instances, given the aggressive nature of the disease, patients are counseled for the need of a cystectomy with urinary diversion [2–4]. While open radical cystectomy with urinary diversion remains the gold standard for treatment of patients with muscle-invasive bladder cancer, robot-assisted surgery has rapidly evolved as an alternative approach, gaining popularity among urologic surgeons [8–11, 26].
Patients are recommended treatment with radical cystectomy and urinary diversion most typically when either muscle-invasive disease is present or when patients have recurrent high-grade T1 and/or CIS disease [2]. Perioperative chemotherapy has a role in many cases, either in the neoadjuvant or adjuvant setting. Neoadjuvant chemotherapy may be particularly desirable among patients with suspected T3 disease and/or evidence of lymphadenopathy on radiographic imaging, in which cases cystectomy may be delayed until after administration of chemotherapy with hopes of debulking tumor burden and potentially treating micrometastatic disease systemically [3, 4]. Factors taken into consideration in preoperative cystectomy counseling include the patient’s baseline performance status, which may also influence selection of the approach to surgery, i.e. robot assisted versus open. .
Traditionally, radical cystectomy with urinary diversion has been an incredibly morbid surgery with significant perioperative mortality and morbidity [5, 27]. Advances in surgical technique, anesthetic care, and postoperative management have dramatically reduced the mortality and morbidity associated with cystectomy [5]. Furthermore, the introduction of robot-assisted surgery into the field of urology has also had an impact in the treatment of bladder cancer. While longer term oncologic and survival comparisons are forthcoming, many studies report benefits utilizing robot-assisted surgery with respect to estimated blood loss, postoperative analgesic usage, and length of stay when compared to the open approach, and intermediate term oncologic outcomes appear comparable [8–11].
Improving Outcomes After Major Abdominal Operations: Lessons from General Surgery
Reducing the mortality and morbidity of radical cystectomy and urinary diversion continues to challenge urologic oncologists today. In contrast to other major urologic oncology procedures, the routine use of intestinal segments for urinary diversion introduces a number of risks and challenges for postoperative recovery. Ileus, bowel obstruction, and other complications consistently rank among the most common and troublesome major complications in series of cystectomy and urinary diversion. Whereas the historical paradigm of bowel surgery was characterized by extreme conservativism, with prolonged nasogastric tube drainage and delayed initiation of enteral feeding until resumption of bowel function was established, standard postoperative care in general surgery has evolved towards earlier introduction of feeding, which in turn appears to be associated with improved outcomes in a variety of contexts [13–21].
A more aggressive approach to postoperative care after colorectal surgery has an established and standardized track record that has been widely adopted. Enhanced recovery after surgery, or ERAS, protocols have repeatedly shown improved postoperative outcomes, leading to widespread adoption of these clinical fast-track pathways in that context [13–19]. Key components of ERAS pathways [13] for patients undergoing colorectal surgery include:
1.
Minimizing preoperative oral bowel preparation, no longer routine for all patients
2.
Preoperative fasting to include NPO for solids 6 h prior and, in some settings, NPO for clear liquids 2 h prior
3.
No preanesthetic anxiolytic or analgesic medications
4.
Antithrombotic prophylaxis as mandated by local protocols
5.
Single dose antimicrobial prophylaxis against both aerobic and anaerobic microorganisms
6.
Patients encouraged and informed about utilization of mid-thoracic epidural
7.
Minimize surgical incisions
8.
Nasogastric tube decompression not be used routinely
9.
Intraoperative maintenance of normothermia with infusion of warmed fluids and upper body air-heating cover
10.
Oral fluids starting 2 h after surgery on day 0 with a target intake of 800 mL on day 0
11.
Goal of discontinuing IV fluids on day 1
12.
No routine placement of intra-abdominal drain
13.
Urinary catheter drainage until epidural is discontinued
14.
Selective use of antiemetics to promote postoperative intake and diminish postoperative nausea
15.
Patients encouraged for early mobilization, out of bed at 2 h postoperatively, and every 6 h thereafter
16.
Discharge criteria include pain management with oral medications, no need for IV fluids, adequate PO intake, independently mobile or at the same level prior to admission
Over the past decade, there have been many modifications and deviations to the fast-track clinical pathway described above, dependent upon the specific surgery performed, but the basic tenets of minimizing bowel preparations, single dose antibiotic prophylaxis, antithrombotic prophylaxis, minimizing gastric decompression, early reintroduction of oral intake, early mobilization, and maintaining adequate but minimal postoperative analgesia continue to have significant relevance in the postoperative care of patients undergoing a broad spectrum of gastrointestinal operations [13–21].
Benefits of Fast-Track Pathways in the General Surgery Experience
A randomized control trial comparing fast-track protocols after colonic surgery compared to older standard protocols was conducted by researchers in Zurich [13]. Muller et al. reported that utilizing fast-track protocols led to significantly reduced 30 day complications and shorter hospital stays, ultimately driving reduced healthcare costs [13]. This trend was also confirmed in a prospective observational study of more than 900 patients undergoing colonic surgery reported by Gustaffsson et al.; patients with high adherence to the ERAS protocol were found to have a 25 % lower risk of a postoperative complication and 50 % lower risk of postoperative symptoms delaying discharge [14].
In parallel with these clinical and economic benefits, fast-track pathways have also been shown to improve satisfaction of both providers and patients. Postoperative care employing fast-track programs require coordinated efforts between all stakeholders including physicians, nurses, dieticians, nursing assistants, patients, and family caregivers [19–21]. The coordinated efforts of all the individuals involved leads to more robust communication, ultimately enhancing patient care [19–21]. Furthermore, from a nursing perspective, nurses in fact play a larger role in postoperative recovery by encouraging early mobilization and oral intake [20, 21]. As a result, nurses feel more invested as the importance of their roles becomes highlighted in the successful implementation of postoperative fast-track recovery programs [20, 21]. Ultimately, as reflected in survey data, this leads to an overall greater patient satisfaction with their operative experience [21]. In a review of enhanced recovery protocols, authors Khan et al. examined ten studies investigating health-related quality of life (HRQoL) and patient satisfaction, with several studies demonstrating significantly reduced fatigue and pain in the first week after surgery [21]. After the first week of surgery, the authors did not find any statistically significant differences in the results of patient questionnaires [21] leading to the conclusion that these pathways may be particularly critical to improving the quality of life during the early days of the postoperative recovery [21].
Radical Cystectomy: Rationale for Adoption of Fast-Track Pathway
Given the centrality of small or large bowel resection and anastomosis for urinary diversion to the recovery after cystectomy, and the significance of these aspects to the development of complications after cystectomy, implementing the strategies of postoperative care from our colleagues in general surgery is intuitive and lends itself to very similar parallels. While the issues central to gastrointestinal surgery are relatively less relevant in other major urologic oncology procedures such as nephrectomy or prostatectomy, the importance of these issues to the recover after radical cystectomy cannot be underestimated. As such, we strongly believe that the incorporation of insights from the general surgery literature into the postoperative care of patients undergoing radical cystectomy with urinary diversion for the treatment of bladder cancer provides an important avenue to improve outcomes, reduce costs, and enhance the patient’s experience and satisfaction.
The UNC Lineberger Experience with Fast-Track Cystectomy Pathway
Our postoperative cystectomy pathway has previously been reported in 362 patients undergoing radical cystectomy from either an open or a robot-assisted approach. Urinary diversions encompassed both ileal conduits and neobladders. The original “fast-track” pathway in our main descriptive report is outlined below:
1.
Counseling and expectations of surgery
2.
Clear liquid diet the day prior to surgery with a bottle of magnesium citrate and a fleets enema taken the night before. We no longer implement this aspect of the pathway; rather patients are encouraged to eat a regular diet the day prior to surgery and no longer administer a mechanical enema for bowel preparation
3.
NPO after midnight the evening prior to surgery
4.
Neomycin enema the day of surgery 2 h prior to start of surgery
5.
Intraoperative DVT prophylaxis with TED hose and SCDs
6.
Perioperative antibiotics with a second or third generation cephalosporin for 24-h coverage
7.
Removal of nasogastric or orogastric tube (if placed) at the end of the surgery
8.
Postoperative DVT prophylaxis with ambulation, TED, SCDs, and subcutaneous heparin or lovenox at the discretion of the attending surgeon
9.
GI ulcer prophylaxis with an H2 blocker
10.
Prokinetic agents (metoclopramide 10 mg IV q8 for 48 h)
11.
Non-narcotic pain management with toradol 30 mg q6 for 48 h, then celebrex 200 mg BID afterwards for 2 weeks with supplementation with morphine and/or other narcotic PCA as needed
12.
Use of toradol as needed if renal function permits
13.
Early ambulation with early consultation with physical therapy
14.
Diet advanced as follows:
(a)
NPO on postoperative day 1
(b)
8 oz of clear liquid diet every 8 h on postoperative day 2 (8 q8, irrespective of bowel sounds)
(c)
Unrestricted clear liquid diet on postoperative day 3
(d)
If clear liquid diet tolerated without significant nausea and/or vomiting, regular diet on postoperative day 4
A number of changes have been made to our initial experience which are outlined later in the chapter. However, even our initial experience highlights several significant shifts from the previously accepted norm. Major changes from traditional practice include immediate removal (or lack of placement) of an orogastric or nasogastric tube and the elimination of preoperative bowel preparation as previously described [13–19]. Initial experience of early nasogastric tube removal concomitantly with metoclopramide use was described by Donat et al. where the authors demonstrated that early nasogastric decompression had benefits with regards to earlier return of bowel function as well as fewer complications with atelectasis [22]. However with our series, we noted no benefit with prolonged NG tube decompression and elected to remove it at the end of the surgical operation starting from the 60th case [6]. Non-narcotic pain management was also an innovation to help prevent exacerbating delayed return of bowel function [6]. Additionally, with the introduction of minimally invasive surgery into the treatment of bladder cancer, particularly with the robot-assisted radical cystectomy, further reduction of narcotic pain requirements has been seen, ultimately facilitating more rapid return of bowel function as well as reducing the length of postoperative hospital stay.
Retrospective analysis of 362 patients with bladder cancers who underwent radical cystectomy with urinary diversion between 2001 and 2008 revealed that patients on the fast-track pathway had shorter time to flatus, bowel movement, and hospital discharge, compared to previously reported literature (see Table 13.1) [6]. Complication and readmission rates were comparable with benchmarks previously reported literature [6].
Table 13.1
Demographics and perioperative outcomes of the 100 most recent patients in the UNC Lineberger fast-track experience
Demographics and perioperative outcomes | |
---|---|
Age | 66.9 (33–86) |
ASA score | 2.7 (2–4) |
Mean time to flatus, d | 2.2 |
Mean time to BM, d | 2.9 |
Mean time to d/c, d | 5.0 |
% D/C on POD 4/5 | 79 % |
Overall complication rate | 39 % |
GI complication rate | 16 % |
Readmission rate | 12 % |
Patients receiving metoclopramide were less likely to experience nausea and vomiting compared to patients not receiving metoclopramide (see Table 13.2). However, the length of stay in the hospital was not significantly different in the two groups and no direct link made towards the progression to a postoperative ileus [6]. Furthermore, patients chewing gum starting on POD 1 experienced reduced time to flatus as well as time to bowel movement after radical cystectomy (see Table 13.3) [7]. These results are similar to literature published detailing the postoperative care after colorectal surgery [13–19]. Our clinical pathway was not modified on the basis of clinical staging, age, comorbidities, open versus robot-assisted surgery, or diversion type.
Table 13.2
Outcomes of metoclopramide treatment after cystectomy [6]